Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised
ABSTRACTObjective The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD) in patients with Parkins...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia Brasileira de Neurologia (ABNEURO)
2015-11-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015001100929&lng=en&tlng=en |
| _version_ | 1819074746219757568 |
|---|---|
| author | Emmanuelle Sobreira Márcio A. Pena-Pereira Alan L. Eckeli Manoel A. Sobreira-Neto Marcos H. N. Chagas Maria P. Foss Brenna Cholerton Cyrus P. Zabetian Ignacio F. Mata Vitor Tumas |
| author_facet | Emmanuelle Sobreira Márcio A. Pena-Pereira Alan L. Eckeli Manoel A. Sobreira-Neto Marcos H. N. Chagas Maria P. Foss Brenna Cholerton Cyrus P. Zabetian Ignacio F. Mata Vitor Tumas |
| author_sort | Emmanuelle Sobreira |
| collection | DOAJ |
| description | ABSTRACTObjective The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD) in patients with Parkinson's disease (PD).Method Both scales were administered to a final convenience sample of 79 patients with PD. Patients were evaluated by a neurologist, a psychiatrist and a neuropsychologist using UPDRS, Hoehn and Yahr and Schwab and England scales, global deterioration scale, a psychiatric structured interview, Mattis Dementia Rating Scale and other cognitive tests.Results There were 32 patients with PDMCI and 17 patients with PDD. The MoCA and the ACE-R were able to discriminate patients with PDD from the others.Conclusion Both scales showed to be useful to screen for dementia but not for mild cognitive impairment in patients with PD. |
| first_indexed | 2024-12-21T18:14:25Z |
| format | Article |
| id | doaj.art-cffb0e3d00a3486aaf4a4612bc2bbf7a |
| institution | Directory Open Access Journal |
| issn | 1678-4227 |
| language | English |
| last_indexed | 2024-12-21T18:14:25Z |
| publishDate | 2015-11-01 |
| publisher | Academia Brasileira de Neurologia (ABNEURO) |
| record_format | Article |
| series | Arquivos de Neuro-Psiquiatria |
| spelling | doaj.art-cffb0e3d00a3486aaf4a4612bc2bbf7a2022-12-21T18:54:42ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-42272015-11-01731192993310.1590/0004-282X20150156S0004-282X2015001100929Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-RevisedEmmanuelle SobreiraMárcio A. Pena-PereiraAlan L. EckeliManoel A. Sobreira-NetoMarcos H. N. ChagasMaria P. FossBrenna CholertonCyrus P. ZabetianIgnacio F. MataVitor TumasABSTRACTObjective The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD) in patients with Parkinson's disease (PD).Method Both scales were administered to a final convenience sample of 79 patients with PD. Patients were evaluated by a neurologist, a psychiatrist and a neuropsychologist using UPDRS, Hoehn and Yahr and Schwab and England scales, global deterioration scale, a psychiatric structured interview, Mattis Dementia Rating Scale and other cognitive tests.Results There were 32 patients with PDMCI and 17 patients with PDD. The MoCA and the ACE-R were able to discriminate patients with PDD from the others.Conclusion Both scales showed to be useful to screen for dementia but not for mild cognitive impairment in patients with PD.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015001100929&lng=en&tlng=enMoCAACE-Rdoença de Parkinsoncomprometimento cognitivo levedemênciaavaliação cognitivatestes neuropsicológicos |
| spellingShingle | Emmanuelle Sobreira Márcio A. Pena-Pereira Alan L. Eckeli Manoel A. Sobreira-Neto Marcos H. N. Chagas Maria P. Foss Brenna Cholerton Cyrus P. Zabetian Ignacio F. Mata Vitor Tumas Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised Arquivos de Neuro-Psiquiatria MoCA ACE-R doença de Parkinson comprometimento cognitivo leve demência avaliação cognitiva testes neuropsicológicos |
| title | Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised |
| title_full | Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised |
| title_fullStr | Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised |
| title_full_unstemmed | Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised |
| title_short | Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised |
| title_sort | screening of cognitive impairment in patients with parkinson s disease diagnostic validity of the brazilian versions of the montreal cognitive assessment and the addenbrooke s cognitive examination revised |
| topic | MoCA ACE-R doença de Parkinson comprometimento cognitivo leve demência avaliação cognitiva testes neuropsicológicos |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015001100929&lng=en&tlng=en |
| work_keys_str_mv | AT emmanuellesobreira screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT marcioapenapereira screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT alanleckeli screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT manoelasobreiraneto screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT marcoshnchagas screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT mariapfoss screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT brennacholerton screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT cyruspzabetian screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT ignaciofmata screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised AT vitortumas screeningofcognitiveimpairmentinpatientswithparkinsonsdiseasediagnosticvalidityofthebrazilianversionsofthemontrealcognitiveassessmentandtheaddenbrookescognitiveexaminationrevised |